D5320C00001: Phase IIa Study of AZD4901 in Polycystic Ovary Syndrome

• Research type

  Research Study

• Full title

  A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females with Polycystic Ovary Syndrome

• IRAS ID

  129832

• Contact name

  Jyothis George

• Contact email

  J.George@ed.ac.uk

• Sponsor organisation

  AstraZeneca

• Eudract number

  2013-000788-98

• REC name

  Scotland A REC

• REC reference

  13/SS/0083

• Date of REC Opinion

  18 Jun 2013

• REC opinion

  Further Information Favourable Opinion